
Ep. 06: CRISPR and its use in cellular therapies
No se pudo agregar al carrito
Solo puedes tener X títulos en el carrito para realizar el pago.
Add to Cart failed.
Por favor prueba de nuevo más tarde
Error al Agregar a Lista de Deseos.
Por favor prueba de nuevo más tarde
Error al eliminar de la lista de deseos.
Por favor prueba de nuevo más tarde
Error al añadir a tu biblioteca
Por favor intenta de nuevo
Error al seguir el podcast
Intenta nuevamente
Error al dejar de seguir el podcast
Intenta nuevamente
-
Narrado por:
-
De:
Acerca de esta escucha
In this episode we talk to Dr. Rasmus O Bak from Aarhus University about the use of CRISPR and its use in cellular therapies. CRISPR has now become a method to not only knock gene’s out but - as Dr. Bak explains - also an all-round tool that can be utilized to a variety of different task.
We discuss research from Dr. Bak’s research group, examining how CRISPRa and CRISPRi - a method to either active or inactivate genes - can be used in both hematopoietic stem cells and T cells to up- and down-regulate genes and push cells into entire new cellular states.
The articles discussed are:
- “Targeted regulation of transcription in primary cells using CRISPRa and CRISPRi” (Link: https://genome.cshlp.org/content/31/11/2120.long)
- 40-year-old associate professor is this year's recipient of the faculty's talent award (Link: https://biomed.au.dk/display/artikel/40-year-old-associate-professor-is-this-years-recipient-of-the-facultys-talent-award)
- “UK first to approve CRISPR treatment for diseases: what you need to know” (Link: https://www.nature.com/articles/d41586-023-03590-6)
Todavía no hay opiniones